Evidence map›Paper›PMID 41901267›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Exploration of Novel Indole Compounds with Potential Activity Against Breast Cancer: Synthesis, Characterization and Anti-Cancer Activity Evaluation.

Eid E Salama, Ashtar A Alrayes, Saad Alrashdi, Ahmed T A Boraei, Nagwa I Ahmed, Salah Eid, Karam S El-Nasser, Haitham Kalil, Ahmed A M Sarhan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eid E SalamaDepartment of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.ORCID 0000-0002-7325-2335
Ashtar A AlrayesDepartment of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.ORCID 0009-0004-0568-6192
Saad AlrashdiDepartment of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.ORCID 0009-0009-2384-5245
Ahmed T A BoraeiDepartment of Chemistry, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.
Nagwa I AhmedInternal Medicine Department, Faculty of Medicine, Suez University, Suez 43511, Egypt.
Salah EidDepartment of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.
Karam S El-NasserDepartment of Chemistry, College of Science, Jouf University, Sakaka 72341, Aljouf, Saudi Arabia.
Haitham KalilDepartment of Chemistry & Biochemistry, California Polytechnic State University, San Luis Obispo, CA 93407, USA.ORCID 0000-0002-5140-1504
Ahmed A M SarhanDepartment of Chemistry, Faculty of Science, Arish University, Al-Arish 45511, Egypt.

Funding

This work was funded by the Deanship of Graduate Studies and Scientific Research at Jouf University DGSSR-2023-02-02475
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anticancerHepG2indolyl-1,2,4-triazolesMCF-7synthesis

Identifiers

PMID41901267
PMCPMC13029243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.